Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 2/20 | 0.38 |
| ▸ | KIT | P10721 | 4/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | FLT3 | P36888 | 4/20 | 0.36 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25209286 | 1.00 | CSF1R (0.38) | CSF1RKITPRMT5WDR77FLT3 | |
| SCHEMBL25294274 | 0.84 | TAAR1 (0.44) | CSF1RKITPRMT5WDR77HTR2A | |
| SCHEMBL25196657 | 0.84 | GPR139 (0.39) | CSF1RKITPRMT5WDR77FLT3 | |
| SCHEMBL25247711 | 0.81 | CYP11B1 (0.34) | PRMT5WDR77FLT3 | |
| SCHEMBL30429657 | 0.79 | HTR2A (0.33) | HTR2A | |
| SCHEMBL25199418 | 0.79 | HTR2A (0.33) | HTR2A | |
| SCHEMBL23114698 | 0.79 | FLT3 (0.42) | CSF1RKITPRMT5WDR77FLT3 | |
| SCHEMBL25521003 | 0.78 | DNMT1 (0.41) | GPR139HTR2A | |
| SCHEMBL25206395 | 0.78 | PRMT5 (0.37) | CSF1RKITPRMT5WDR77FLT3 | |
| SCHEMBL30429613 | 0.78 | PRMT5 (0.37) | CSF1RKITPRMT5WDR77FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423060-A2 | PSYCHOPLASTOGENIC N-SUBSTITUTED INDOLES | Terran Biosciences, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023077127-A2 | N-SUBSTITUTED INDOLES | TERRAN BIOSCIENCES, INC. (US) | 2023-05-04 | — | — | WO | disclosed |